Drug Information

Drug General Information
Drug ID
D05BPD
Former ID
DNCL002698
Drug Name
Emepepimut-S
Drug Type
Vaccine
Indication Non-small cell lung cancer [ICD10:C33-C34] Phase 2 [522556]
Company
EMD Serono; Oncothyreon
Target and Pathway
Target(s) Mucin 1 Target Info [531524]
WikiPathways Hematopoietic Stem Cell Differentiation
References
Ref 522556ClinicalTrials.gov (NCT00828009) BLP25 Liposome Vaccine and Bevacizumab After Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Stage IIIA or Stage IIIB Non-Small Cell LungCancer That Cannot Be Removed by Surgery. U.S. National Institutes of Health.
Ref 531524Emepepimut-S for non-small cell lung cancer. Expert Opin Biol Ther. 2011 Aug;11(8):1091-7.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.